Literature DB >> 19698849

Influence of prosthesis-patient mismatch on exercise-induced arrhythmias: a further aspect after aortic valve replacement.

Vito Antonio Mannacio1, Vincenzo De Amicis, Luigi Di Tommaso, Francesco Iorio, Carlo Vosa.   

Abstract

OBJECTIVES: The influence of prosthesis-patient mismatch on outcome after aortic valve replacement is controversial. This study analyzed the impact of prosthesis-patient mismatch on survival, the extent of left ventricular mass, and physical capacity after replacement with a small-size prosthesis. PATIENTS AND METHODS: A total of 157 patients who underwent valve replacement for pure aortic stenosis were reviewed. Late mortality, morbidity, left ventricular mass regression, transprosthetic gradient at rest and after exercise, exercise capacity, and occurrence of arrhythmias were evaluated.
RESULTS: Prosthesis-patient mismatch, defined as an indexed effective orifice area of 0.75 cm(2)/m(2) or more, occurred in 96 (61.1%) patients and had no significant impact on early and late mortality. The only independent predictor of mortality was age greater than 65 years. At follow-up, multivariate analysis of prosthetic gradient at rest of 35 mm Hg end exercise capacity or more revealed that both these evidences were associated with high left ventricular mass (P < .001), female gender (P < .001), and follow-up time (P < .001). Arrhythmias occurred during exercise in 34.1% of patients (40/117). Multivariate analysis of occurrence of arrhythmias revealed that they were associated with high mean transprosthetic gradients: values of 50 mm Hg or more during exercise had 95% sensitivity and 72% specificity for predicting arrhythmias.
CONCLUSION: Prosthesis-patient mismatch failed to demonstrate any significant impact on early and late mortality and morbidity and in left ventricular mass regression. High transprosthetic gradients influence exercise capacity and occurrence of arrhythmias.

Entities:  

Mesh:

Year:  2009        PMID: 19698849     DOI: 10.1016/j.jtcvs.2009.01.009

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  8 in total

Review 1.  A 44-year experience of prosthetic heart valve implantation at Niigata University Hospital.

Authors:  Jun-ichi Hayashi
Journal:  J Artif Organs       Date:  2012-04-24       Impact factor: 1.731

2.  B-type natriuretic peptide as a biochemical marker of left ventricular diastolic function: assessment in asymptomatic patients 1 year after valve replacement for aortic stenosis.

Authors:  Vito Mannacio; Anita Antignano; Vincenzo De Amicis; Luigi Di Tommaso; Raffaele Giordano; Gabriele Iannelli; Carlo Vosa
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-05-08

3.  Long-term results after aortic root replacement using self-assembled valve composite grafts in patients with small aortic annulus.

Authors:  Paul P Urbanski; Witold Dinstak; Wilko Rents; Nicolas Heinz; Anno Diegeler
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-10-30

Review 4.  Prosthesis-patient mismatch: an update.

Authors:  Jean G Dumesnil; Philippe Pibarot
Journal:  Curr Cardiol Rep       Date:  2011-06       Impact factor: 2.931

Review 5.  Exercise hemodynamics in valvular heart disease.

Authors:  Anna M Booher; David S Bach
Journal:  Curr Cardiol Rep       Date:  2011-06       Impact factor: 2.931

6.  Aortic valve reconstruction with use of pericardial leaflets in adults with bicuspid aortic valve disease: early and midterm outcomes.

Authors:  Meong Gun Song; Hyun Suk Yang; Jong Bum Choi; Je Kyoun Shin; Hyun Keun Chee; Jun Seok Kim
Journal:  Tex Heart Inst J       Date:  2014-12-01

Review 7.  Update on aortic valve prosthesis-patient mismatch in Japan.

Authors:  Yoshimasa Sakamoto; Kazuhiro Hashimoto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-04-13

8.  Factors determining patient-prosthesis mismatch after aortic valve replacement--a prospective cohort study.

Authors:  Diana Bonderman; Alexandra Graf; Andreas A Kammerlander; Alfred Kocher; Guenter Laufer; Irene M Lang; Julia Mascherbauer
Journal:  PLoS One       Date:  2013-12-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.